News

October 31, 2008 - TCT India Live is a three-day symposium designed for interventional cardiologists, clinical ...

Home October 30, 2008
Home
Feature | Ellen W. Rothschild, RN, MS

There is considerable interest in being able to clearly identify vulnerable plaque (VP) and research efforts are intensifying. Several invasive imaging technologies claim to detect VP, and while the link between VP identification, plaque rupture and clinical events has yet to be firmly established, progress is being made in the research.

Home October 30, 2008
Home
Technology

GE Healthcare’s recently released Vivid E9 ultrasound features Accelerated Volume Architecture (AVA), which not only makes single beat acquisition possible but, working alongside Extended Signal transducer technology in each probe, it reportedly delivers a leap in 2D, 4D and shared service image quality across the entire patient population.

Home October 30, 2008
Home
Technology

Micrus Endovascular Corp. initiated its worldwide launch of Neuropath guide catheter line, designed with a highly flexible and visible tip so neurointerventionalists can gain better vessel access and greater vessel selection in treating patients with complex anatomies.

Home October 30, 2008
Home
Technology

CardioECG 3.2, introduced by LUMEDX Corp. and Epiphany Cardiography Products, is a multimodality, multivendor, pure-Web ...

Home October 30, 2008
Home
Technology

The nSPEED reconstruction software from Digirad Corp. is for use in its imaging systems for SPECT procedures at either half-time and/or half count densities with parallel and nonparallel hole collimators, reportedly resulting in quicker exams, improved image quality and less radiation exposure.

Home October 30, 2008
Home
Technology

The FDA granted approval for Covidien’s generic kit for the preparation of technetium Tc99m Sestamibi injection use for nuclear myocardial perfusion imaging.

Home October 30, 2008
Home
Technology

Just ahead of the expected release of clinical practice guidelines on Familial Hypercholesterolaemia (FH) by the influential National Institute for Clinical Excellence (NICE), Tepnel Life Sciences PLC launched a DNA test for the early detection of FH, a genetic condition that predisposes individuals to high blood cholesterol levels and increased risk of cardiovascular disease.

Home October 30, 2008
Home
News

October 31, 2008 - Surface modification and drug delivery technologies company SurModics Inc. said today it is providing ...

Home October 30, 2008
Home
Feature | Nick Obradovich

"Potential” can be a loaded word, especially in healthcare. Many clinicians have tagged coronary MR angiography (MRA) with the “potential” label. Despite the scan’s reported safety advantages over coronary CT angiography (CTA), as well as its superior physiologic information, coronary MRA has not gained the widespread acceptance of coronary CTA.

Home October 30, 2008
Home
Technology

Stereotaxis Inc. said the FDA cleared its magnetically tipped PowerAssert radiofrequency (RF) guide wire to cross chronic total occlusions (CTOs) in the peripheral vasculature.

Home October 30, 2008
Home
Technology

Boston Scientific's TAXUS Express2 Atom paclitaxel-eluting coronary stent system is a drug-eluting stent (DES) specifically designed for treating small coronary vessels. The TAXUS Express2 Atom Stent System is the only DES approved by the FDA for use in vessels as small as 2.25 mm in diameter, Boston Scientific said. The Taxus Express 2 Atom received FDA approval in the fall of 2008.

Home October 30, 2008
Home
News

October 31, 2008 - Corgenix Medical Corp. recently said new CHARISMA trial findings published in Circulation confirm ...

Home October 30, 2008
Home
Feature | Maureen Leahy-Patano

Cardiovascular care does not occur in a single hospital setting; more often than not patients undergo a variety of tests at different locations. In order to provide the best care possible, physicians need immediate access to all patient information, no matter where, when or how it was obtained.

Home October 30, 2008
Home
Technology

St. Jude Medical said the FDA cleared its SJM Confirm implantable cardiac monitor (ICM), a compact device designed to help physicians diagnose abnormal heart rhythms.

Home October 30, 2008
Home
Subscribe Now